SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036529
Filing Date
2024-08-09
Accepted
2024-08-09 17:03:13
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20240630.htm   iXBRL 10-Q 821555
2 EX-31.1 a2024q2-exhibit311.htm EX-31.1 12674
3 EX-31.2 a2024q2-exhibit312.htm EX-31.2 12667
4 EX-32.1 a2024q2-exhibit321.htm EX-32.1 6873
  Complete submission text file 0001628280-24-036529.txt   4353343

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20240630.xsd EX-101.SCH 31616
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20240630_cal.xml EX-101.CAL 50455
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20240630_def.xml EX-101.DEF 114773
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20240630_lab.xml EX-101.LAB 429603
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20240630_pre.xml EX-101.PRE 290934
60 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20240630_htm.xml XML 464289
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 241193852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)